Robust Growth of the Neurological Biomarkers Market Driven by Rising Prevalence of Neurological Diseases
The Business Research Company’s Neurological Biomarkers Global Market Report 2023 – Market Size, Trends, And Market Forecast 2023-2032
LONDON, GREATER LONDON, UK, October 24, 2023 /EINPresswire.com/ -- The neurological biomarkers market is anticipated to reach $15.07 billion in 2027, exhibiting a compound annual growth rate (CAGR) of 12.3%.
Catalyst: Escalating Neurological Disease Prevalence
The surge in neurological diseases continues to be a significant driver of growth in the neurological biomarkers market. These biomarkers play a crucial role in providing early diagnoses of neurological disorders such as Parkinson's disease, aiding in pathological, biochemical, and genetic testing. As reported by the Parkinson's Foundation in December 2022, the diagnosis of new Parkinson's disease cases rose to 90,000 in 2022, compared to 60,000 annually in 2021, underscoring the critical need for effective neurological biomarkers to facilitate timely intervention and treatment.
Drug Development Agreements as Market Trend
Industry leaders are actively engaged in forging strategic drug development agreements to bolster their product portfolios and sustain their competitive positions. Notably, Johnson & Johnson Services Inc.'s collaboration with Enigma Biomedical Group in August 2020 is emblematic of the industry's drive to advance research and understanding of various neurological disorders, including Alzheimer's disease and other dementias, through the assessment of novel neuroimaging biomarkers such as JNJ-64413739 and JNJ-64511070.
Explore the latest trends and growth opportunities in the Global Neurological Biomarkers Market with our sample report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=12677&type=smp
Strategic Acquisitions for Portfolio Expansion
Strategic acquisitions, like GE Healthcare's acquisition of Zionexa in May 2021, are instrumental in enhancing companies' capabilities and expanding their portfolios of precision cancer medicines. Zionexa, known for its innovative molecular technologies, especially in the field of in vivo oncology and neurology biomarkers, brings significant expertise and resources to the portfolio of GE Healthcare.
Key Market Players
Leading entities driving growth and innovation in the neurological biomarkers market include Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, and Thermos Fisher Scientific Inc., among others. These market players are at the forefront of research and development, continuously striving to meet the evolving demands of the market.
Geographical Analysis
North America retained its position as the largest region in the neurological biomarkers market in 2022, with Asia-Pacific expected to witness the fastest growth during the forecast period. The report encompasses a comprehensive analysis of regions, including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Market Segmentation:
•Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products
•Application: Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy
•End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users
Gain comprehensive insights into the factors driving the growth of the Global Neurological Biomarkers Market with our detailed report –
https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report
Neurological Biomarkers Global Market Report 2023 from TBRC covers the following information:
•Market size date for the forecast period: Historical and Future
•Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Neurological Biomarkers Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on neurological biomarkers market size, neurological biomarkers market drivers and trends, neurological biomarkers market major players, competitors' revenues, neurological biomarkers market positioning, and neurological biomarkers market growth across geographies. The neurological biomarkers market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Biomarkers Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report
Renal Biomarkers Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-biomarkers-global-market-report
About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 3000+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Check out our:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
YouTube
Food and Beverages Market Growth Forecast 2023-2027
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
